Renoprotective effects of SGLT2 inhibitors in patients with Fabry disease
{{output}}
Background: Fabry disease (FD) is a rare X-linked lysosomal storage disorder characterized by globotriaosylceramide (Gb3) accumulation, resulting in kidney and cardiac dysfunction. Although enzyme replacement therapy (ERT) and ch... ...
